+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry



Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry



Drug Metabolism and Pharmacokinetics 24(2): 130-138



A technique utilizing simultaneous intravenous microdosing of (14)C-labeled drug with oral dosing of non-labeled drug for measurement of absolute bioavailability was evaluated using R-142086 in male dogs. Plasma concentrations of R-142086 were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and those of (14)C-R-142086 were measured by accelerator mass spectrometry (AMS). The absence of metabolites in the plasma and urine was confirmed by a single radioactive peak of the parent compound in the chromatogram after intravenous microdosing of (14)C-R-142086 (1.5 microg/kg). Although plasma concentrations of R-142086 determined by LC-MS/MS were approximately 20% higher than those of (14)C-R-142086 as determined by AMS, there was excellent correlation (r=0.994) between both concentrations after intravenous dosing of (14)C-R-142086 (0.3 mg/kg). The oral bioavailability of R-142086 at 1 mg/kg obtained by simultaneous intravenous microdosing of (14)C-R-142086 was 16.1%, this being slightly higher than the value (12.5%) obtained by separate intravenous dosing of R-142086 (0.3 mg/kg). In conclusion, on utilizing simultaneous intravenous microdosing of (14)C-labeled drug in conjunction with AMS analysis, absolute bioavailability could be approximately measured in dogs, but without total accuracy. Bioavailability in humans may possibly be approximately measured at an earlier stage and at a lower cost.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056794025

Download citation: RISBibTeXText

PMID: 19430168

DOI: 10.2133/dmpk.24.130


Related references

Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies. Analytical Chemistry 84(11): 4844-4850, 2012

Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39(2): 174-179, 2011

Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay. Analytical Chemistry 84(22): 10031-7, 2013

The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers. Journal of Clinical Pharmacology 45(10): 1198-1205, 2005

19th Montreux Symposium on Liquid Chromatography-Mass Spectrometry, Supercritical Fluid Chromatography-Mass Spectrometry, Capillary Electrophoresis-Mass Spectrometry and Tandem Mass Spectrometry, Leiden and Zeist, Netherlands, 6-8 November, 2002. Journal of Chromatography, A 1020(1): 151 pp., 2003

Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionisation mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 17(3): 215-221, 2003

Assessment of the pollutant elimination efficiency by gas chromatography/mass spectrometry, liquid chromatography-mass spectrometry and -tandem mass spectrometry. Comparison of conventional and membrane-assisted biological wastewater treatment processes. Journal of Chromatography A 889(1-2): 155-176, 11 August, 2000

Analysis of estrogens in river sediments by liquid chromatography-electrospray ionisation mass spectrometry. Comparison of tandem mass spectrometry and time-of-flight mass spectrometry. Journal of Chromatography. a 1141(2): 174-181, 2007

17th Montreux Symposium on Liquid Chromatography-Mass Spectrometry, Supercritical Fluid Chromatography-Mass Spectrometry, Capillary Electrophoresis-Mass Spectrometry and Tandem Mass Spectrometry, Montreux, Switzerland, 8-10 November 2000. Journal of Chromatography, A 926(1): viii + 228 pp., 2001

9th Montreux Symposium on Liquid Chromatography-Mass Spectrometry, Supercritical Fluid Chromatography-Mass Spectrometry, Capillary Zone Electrophoresis-Mass Spectrometry and Tandem Mass Spectrometry Montreux, Switzerland, November 4-6, 1992. Journal of Chromatography 647(1): 1-181, 1993

11th Montreux Symposium on Liquid Chromatography--Mass Spectrometry, Supercritical Fluid Chromatography--Mass Spectrometry, Capillary Electrophoresis--Mass Spectrometry and Tandem Mass Spectrometry. Montreux, Switerland, 9-11 November 1994. Journal of Chromatography. A 712(1): 1-284, 1995

15th Montreux Symposium on Liquid Chromatography-Mass Spectrometry, Supercritical Fluid Chromatography-Mass Spectrometry, Capillary Electrophoresis-Mass Spectrometry and Tandem Mass Spectrometry, Montreux, Switzerland, 11-13 November 1998. Journal of Chromatography, A 854(1/2): viii + 295 pp., 1999

23rd Montreux Symposium on liquid chromatography-mass spectrometry, supercritical fluid chromatography-mass spectrometry, capillary electrophoresis-mass spectrometry and tandem mass spectrometry, Montreux, Switzerland, 8-10 November 2006. Journal of Chromatography, A 1160(1/2): 347 pp, 2007

Pertussis toxoid structure: a collaboration and comparison of two-dimensional liquid chromatography-tandem mass spectrometry, ultraperformance liquid chromatography-mass spectrometryE, and capillary liquid chromatography-matrix-assisted laser desorption ionization-tandem mass spectrometry. Analytical Biochemistry 437(1): 40-42, 2013

Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies. Analytical Chemistry 83(14): 5607-5616, 2012